Here is what most people actually experience versus what they expect
How GLP-1 agonists work Multiple mechanisms: Slow gastric emptying (food stays in stomach longer, you feel full longer) Signal satiety to brain (reduce hunger at neurological level) Improve insulin sensitivity (better blood sugar control) Reduce cravings (especially for hyperpalatable foods) May increase metabolism slightly Why they're so effective: They address the biological drivers of overeating, not just willpower
Posted on behalf of IVDrips
doi: 10.2337/dc22-1889 [DOI] [PMC free article] [PubMed] [Google Scholar] 106.MacIsaac RJ, Trevella P, Ekinci EI
In addressing these issues early, the goal is also to reduce the risk of major adverse cardiovascular events (Medscape)
Treatment for kidney disease The positive results from FLOW demonstrate[d] the potential for semaglutide to become the first GLP-1 treatment option for people living with type 2 diabetes and chronic kidney disease, Lange said at the time study results were released
